These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2948042)
21. Dissociation of hemodynamic and coronary arterial tolerance to nitroglycerin in dogs. Miyauchi N; Takahashi M; Fujioka H; Kinoshita M J Cardiovasc Pharmacol; 1993 May; 21(5):767-73. PubMed ID: 7685447 [TBL] [Abstract][Full Text] [Related]
22. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation. Pizzulli L; Hagendorff A; Zirbes M; Fehske W; Ewig S; Jung W; Lüderitz B Am Heart J; 1996 Feb; 131(2):342-9. PubMed ID: 8579031 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs. Nakae I; Quan L; Hashimoto K; Sugimoto Y; Tsutamoto T; Kinoshita M Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324 [TBL] [Abstract][Full Text] [Related]
24. Effect of KRN2391 on venous return: comparison with other vasodilators. Kaneta S; Jinno Y; Miwa A; Fukushima H; Ogawa N J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101 [TBL] [Abstract][Full Text] [Related]
25. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review. Kato K Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372 [TBL] [Abstract][Full Text] [Related]
26. Effects of 2-nicotinamidethyl nitrate (SG-75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs. Mizukami M; Tomoike H; Inouh T; Watanabe K; Kikuchi Y; Nakamura M Arzneimittelforschung; 1981; 31(8):1244-7. PubMed ID: 6457606 [TBL] [Abstract][Full Text] [Related]
27. Effects of nicorandil on the conductive coronary artery of the dog. Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog. Preuss KC; Gross GJ; Brooks HL; Warltier DC J Cardiovasc Pharmacol; 1985; 7(4):709-14. PubMed ID: 2410712 [TBL] [Abstract][Full Text] [Related]
29. Cardiohaemodynamic effects of long-term intravenous administration of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75), a potent coronary vasodilator: comparison with glyceryl trinitrate. Sakai K; Shiraki Y; Yamazaki T; Akima M; Nabata H; Ohba Y Clin Exp Pharmacol Physiol; 1981; 8(6):557-65. PubMed ID: 6460572 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate. Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065 [TBL] [Abstract][Full Text] [Related]
31. Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. Akai K; Wang Y; Sato K; Sekiguchi N; Sugimura A; Kumagai T; Komaru T; Kanatsuka H; Shirato K J Cardiovasc Pharmacol; 1995 Oct; 26(4):541-7. PubMed ID: 8569213 [TBL] [Abstract][Full Text] [Related]
32. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. Gross GJ; Pieper GM; Warltier DC J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429 [TBL] [Abstract][Full Text] [Related]
33. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs. Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711 [TBL] [Abstract][Full Text] [Related]
34. Effects of a new coronary vasodilator, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) and nitroglycerin on cardiovascular hemodynamics in young and aged beagle dogs. Sakai K; Aono J; Haruta K Jpn J Pharmacol; 1981 Apr; 31(2):281-5. PubMed ID: 6458720 [No Abstract] [Full Text] [Related]
35. Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs. Wynsen JC; Gross GJ; Brooks HL; Warltier DC J Pharmacol Exp Ther; 1987 Jun; 241(3):846-54. PubMed ID: 2885410 [TBL] [Abstract][Full Text] [Related]
36. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505 [TBL] [Abstract][Full Text] [Related]
37. Hemodynamic tolerance and pharmacokinetics of nicorandil in experimental heart failure. Bachert EL; Fung HL J Cardiovasc Pharmacol; 1993 May; 21(5):781-5. PubMed ID: 7685449 [TBL] [Abstract][Full Text] [Related]
38. Effects of a new antianginal agent, nicorandil, on the cardiovascular system of the miniature pig: with special reference to coronary vasospasm. Sakai K; Akima M; Shiraki Y; Hoshino E J Pharmacol Exp Ther; 1983 Oct; 227(1):220-8. PubMed ID: 6225867 [TBL] [Abstract][Full Text] [Related]
39. Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers. Tabone X; Funck-Brentano C; Billon N; Jaillon P Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):672-9. PubMed ID: 7995010 [TBL] [Abstract][Full Text] [Related]
40. Coronary effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs. Hashimoto K; Kinoshita M; Ohbayashi Y Cardiovasc Drugs Ther; 1991 Feb; 5(1):131-8. PubMed ID: 1827988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]